Back to search

United Kingdom· GB-APID-3886211000001102

Corgaretic 40mg tablets

A medicinal product containing nadolol + bendroflumethiazide, registered in United Kingdom by Sanofi-Synthelabo Ltd.

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedCorgaretic 40mg tabletsATC—REGISTER NO.GB-APID-3886211000001…PACKS LISTED0CHECKEDSeptember 13, 2026

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Nadolol + Bendroflumethiazide
Manufacturer
Sanofi-Synthelabo Ltd
Country
United Kingdom (GB)
ATC code
—
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8fa381e6-b3ac-4102-b44f-5eb17a94f063
GET /v1/drugs/8fa381e6-b3ac-4102-b44f-5eb17a94f063?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "3886211000001102",
  "desc": "Corgaretic 40mg tablets (Sanofi-Synthelabo Ltd)",
  "form": "Oral tablet",
  "vpid": "42377711000001108",
  "source": "dmd",
  "vtm_id": "774765006",
  "strength": "40 mg",
  "substance": "Nadolol + Bendroflumethiazide",
  "ingredient": "Nadolol",
  "supplier_code": "2086301000001103"
}

See everything about nadolol + bendroflumethiazide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.